PREFERRED STOCK	12 Months Ended
Dec. 31, 2025
Equity [Abstract]
PREFERRED STOCK	NOTE 6 – PREFERRED STOCK On March 4, 2024, the Company amended its Articles of Incorporation, in which the authorized Preferred Stock was increased to 15,000,000 pursuant to the approved by the BOD and shareholders Plan and Merger Agreement. As of December 31, 2024, pursuant to the terms of the Merger with Nika BioTechnology, Inc (Note 1), the Company issued 5,000,000 shares of preferred stock. Currently, there are 15,000,000 Preferred Stock issued and outstanding.

The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Name:	us-gaap_PreferredStockTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration